PMVP Earnings

Quarterly EPS
$-0.37
Q3 2024
$-0.44
Q4 2024
$-0.34
Q1 2025
$-0.41
Q2 2025
$-0.40
Q3 2025
$-0.34
Q4 2025
$-0.34
Q1 2026
$-0.34
Q2 2026
Latest RevenueN/A
Latest Net Income-18086000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.340-18086000+17.1%
Q1 2026-$0.340-18038000+0.0%
Q4 2025-$0.340-18037000+22.7%
Q3 2025-$0.400-21059000-8.1%
Q2 2025-$0.410-21210000-1,950.0%
Q1 2025-$0.340-17436000-13.3%
Q4 2024-$0.440-23000000-41.9%
Q3 2024-$0.370-19226000-8.8%
Q2 2024-$0.020-1213000
Q1 2024-$0.300-15270000
Q4 2023-$0.310-15756000
Q3 2023-$0.340-16640000
PMV Pharmaceuticals (PMVP) — Earnings